FDA, CMS launch pilot program for voluntary parallel review of innovative devices
The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) today launched a parallel review pilot program for concurrent review of medical devices for FDA approval and Medicare coverage.